Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zfp691
|
ENSMUSG00000045268.7 | zinc finger protein 691 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_119173322_119174175 | Zfp691 | 108 | 0.926533 | -0.50 | 4.0e-05 | Click! |
chr4_119174430_119174596 | Zfp691 | 318 | 0.780032 | -0.32 | 1.4e-02 | Click! |
chr4_119170364_119170515 | Zfp691 | 3417 | 0.117217 | -0.25 | 5.7e-02 | Click! |
chr4_119179914_119180065 | Zfp691 | 5794 | 0.094633 | -0.21 | 1.1e-01 | Click! |
chr4_119172218_119172369 | Zfp691 | 1563 | 0.212571 | -0.18 | 1.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_64081481_64082460 | 39.37 |
Gm20670 |
predicted gene 20670 |
24368 |
0.15 |
chr17_3037886_3038571 | 38.32 |
Gm49792 |
predicted gene, 49792 |
3796 |
0.13 |
chr17_3034870_3035604 | 30.02 |
Gm49792 |
predicted gene, 49792 |
6787 |
0.12 |
chr7_64074889_64075631 | 29.61 |
Gm20670 |
predicted gene 20670 |
17658 |
0.16 |
chr3_3024695_3025111 | 29.54 |
Gm27460 |
predicted gene, 27460 |
2854 |
0.34 |
chr7_64089421_64089941 | 28.38 |
Gm20670 |
predicted gene 20670 |
32079 |
0.13 |
chr17_3022387_3022720 | 27.89 |
Gm49792 |
predicted gene, 49792 |
19471 |
0.11 |
chr17_3011957_3012639 | 27.60 |
Gm49792 |
predicted gene, 49792 |
29726 |
0.11 |
chr3_3015710_3016211 | 27.08 |
Gm28002 |
predicted gene, 28002 |
11731 |
0.24 |
chr3_3029784_3030583 | 26.51 |
Gm27460 |
predicted gene, 27460 |
2426 |
0.37 |
chr17_3010082_3010582 | 24.98 |
Gm49792 |
predicted gene, 49792 |
31692 |
0.11 |
chr7_64073779_64074278 | 24.77 |
Gm20670 |
predicted gene 20670 |
16426 |
0.16 |
chr3_3015024_3015367 | 24.19 |
Gm28002 |
predicted gene, 28002 |
10966 |
0.24 |
chr17_3030808_3031387 | 22.31 |
Gm49792 |
predicted gene, 49792 |
10927 |
0.11 |
chr17_3006693_3007580 | 21.84 |
Gm49792 |
predicted gene, 49792 |
34888 |
0.1 |
chr17_3035924_3036918 | 21.72 |
Gm49792 |
predicted gene, 49792 |
5603 |
0.12 |
chr17_3009071_3009332 | 21.70 |
Gm49792 |
predicted gene, 49792 |
32823 |
0.11 |
chr7_64085192_64085689 | 21.29 |
Gm20670 |
predicted gene 20670 |
27838 |
0.14 |
chr16_3238204_3238598 | 21.13 |
Gm23215 |
predicted gene, 23215 |
11183 |
0.18 |
chr17_3011315_3011640 | 21.07 |
Gm49792 |
predicted gene, 49792 |
30547 |
0.11 |
chr16_3240083_3240380 | 20.21 |
Gm23215 |
predicted gene, 23215 |
9353 |
0.18 |
chr17_3008609_3009050 | 19.00 |
Gm49792 |
predicted gene, 49792 |
33195 |
0.11 |
chr3_3003169_3003555 | 18.47 |
Gm28002 |
predicted gene, 28002 |
867 |
0.7 |
chr3_3031826_3032492 | 18.17 |
Gm27460 |
predicted gene, 27460 |
4402 |
0.29 |
chr17_3014512_3015356 | 17.98 |
Gm49792 |
predicted gene, 49792 |
27090 |
0.11 |
chr17_3011748_3011899 | 17.51 |
Gm49792 |
predicted gene, 49792 |
30201 |
0.11 |
chr4_3065554_3065809 | 17.43 |
Gm27878 |
predicted gene, 27878 |
13862 |
0.21 |
chr3_3011001_3011345 | 17.38 |
Gm28002 |
predicted gene, 28002 |
6944 |
0.26 |
chr17_3018263_3018685 | 17.31 |
Gm49792 |
predicted gene, 49792 |
23550 |
0.11 |
chr4_3064298_3064624 | 17.20 |
Gm27878 |
predicted gene, 27878 |
12642 |
0.21 |
chr3_3009409_3009718 | 16.86 |
Gm28002 |
predicted gene, 28002 |
5334 |
0.27 |
chr17_3032042_3032580 | 16.84 |
Gm49792 |
predicted gene, 49792 |
9713 |
0.11 |
chr17_3016511_3017014 | 16.69 |
Gm49792 |
predicted gene, 49792 |
25262 |
0.11 |
chr17_3028392_3028642 | 16.47 |
Gm49792 |
predicted gene, 49792 |
13507 |
0.11 |
chr17_3013624_3013846 | 16.24 |
Gm49792 |
predicted gene, 49792 |
28289 |
0.11 |
chr17_3038576_3038924 | 16.20 |
Gm49792 |
predicted gene, 49792 |
3274 |
0.14 |
chr3_3023493_3023784 | 15.93 |
Gm27460 |
predicted gene, 27460 |
4119 |
0.29 |
chr3_3013635_3013896 | 15.70 |
Gm28002 |
predicted gene, 28002 |
9536 |
0.25 |
chr7_64086410_64086672 | 15.60 |
Gm20670 |
predicted gene 20670 |
28939 |
0.14 |
chr4_3054718_3055412 | 15.56 |
Gm27878 |
predicted gene, 27878 |
3246 |
0.3 |
chr17_3015945_3016287 | 15.53 |
Gm49792 |
predicted gene, 49792 |
25908 |
0.11 |
chr3_3007541_3007960 | 15.48 |
Gm28002 |
predicted gene, 28002 |
3521 |
0.31 |
chr3_3012170_3013000 | 15.36 |
Gm28002 |
predicted gene, 28002 |
8356 |
0.25 |
chr17_3012960_3013500 | 15.06 |
Gm49792 |
predicted gene, 49792 |
28794 |
0.11 |
chr3_3003818_3004127 | 14.95 |
Gm28002 |
predicted gene, 28002 |
257 |
0.95 |
chr17_3033660_3034057 | 14.85 |
Gm49792 |
predicted gene, 49792 |
8166 |
0.11 |
chr4_3058967_3059259 | 14.83 |
Gm27878 |
predicted gene, 27878 |
7294 |
0.24 |
chr4_3050476_3050669 | 14.52 |
Gm27878 |
predicted gene, 27878 |
1247 |
0.54 |
chr17_3026976_3027333 | 14.28 |
Gm49792 |
predicted gene, 49792 |
14870 |
0.11 |
chr7_64078870_64079114 | 14.20 |
Gm20670 |
predicted gene 20670 |
21390 |
0.15 |
chr7_64081117_64081411 | 14.05 |
Gm20670 |
predicted gene 20670 |
23662 |
0.15 |
chr17_3017314_3017605 | 13.95 |
Gm49792 |
predicted gene, 49792 |
24565 |
0.11 |
chr7_64082692_64083022 | 13.53 |
Gm20670 |
predicted gene 20670 |
25255 |
0.14 |
chr17_3019209_3019414 | 13.38 |
Gm49792 |
predicted gene, 49792 |
22713 |
0.11 |
chr3_3013205_3013609 | 13.37 |
Gm28002 |
predicted gene, 28002 |
9178 |
0.25 |
chr17_3037356_3037743 | 13.10 |
Gm49792 |
predicted gene, 49792 |
4475 |
0.13 |
chr17_3028672_3028985 | 12.84 |
Gm49792 |
predicted gene, 49792 |
13196 |
0.11 |
chr7_64079568_64079876 | 12.81 |
Gm20670 |
predicted gene 20670 |
22120 |
0.15 |
chr17_3024671_3024881 | 12.80 |
Gm49792 |
predicted gene, 49792 |
17248 |
0.11 |
chr3_3031277_3031510 | 12.67 |
Gm27460 |
predicted gene, 27460 |
3636 |
0.31 |
chr17_3007956_3008300 | 12.50 |
Gm49792 |
predicted gene, 49792 |
33896 |
0.1 |
chr7_64080253_64080652 | 12.31 |
Gm20670 |
predicted gene 20670 |
22850 |
0.15 |
chr17_3028999_3029150 | 12.27 |
Gm49792 |
predicted gene, 49792 |
12950 |
0.11 |
chr4_3055917_3056559 | 12.22 |
Gm27878 |
predicted gene, 27878 |
4419 |
0.27 |
chr7_64088199_64088664 | 12.14 |
Gm20670 |
predicted gene 20670 |
30829 |
0.13 |
chr7_64084637_64084964 | 11.92 |
Gm20670 |
predicted gene 20670 |
27198 |
0.14 |
chr16_3239510_3239751 | 11.92 |
Gm23215 |
predicted gene, 23215 |
9954 |
0.18 |
chr3_3026281_3026806 | 11.51 |
Gm27460 |
predicted gene, 27460 |
1214 |
0.57 |
chr16_3231548_3231828 | 11.12 |
Gm23215 |
predicted gene, 23215 |
17896 |
0.17 |
chr3_3026860_3027081 | 11.11 |
Gm27460 |
predicted gene, 27460 |
787 |
0.73 |
chr4_3062483_3062730 | 10.88 |
Gm27878 |
predicted gene, 27878 |
10787 |
0.22 |
chr3_3029335_3029587 | 10.74 |
Gm27460 |
predicted gene, 27460 |
1704 |
0.46 |
chr3_3007212_3007493 | 10.52 |
Gm28002 |
predicted gene, 28002 |
3123 |
0.33 |
chr17_3024243_3024560 | 10.50 |
Gm49792 |
predicted gene, 49792 |
17623 |
0.11 |
chr4_3058519_3058943 | 10.44 |
Gm27878 |
predicted gene, 27878 |
6912 |
0.24 |
chr4_3054067_3054522 | 10.42 |
Gm27878 |
predicted gene, 27878 |
2475 |
0.34 |
chr3_3001703_3002148 | 10.38 |
Gm28002 |
predicted gene, 28002 |
2304 |
0.39 |
chr17_3017748_3017957 | 10.38 |
Gm49792 |
predicted gene, 49792 |
24172 |
0.11 |
chr7_64083444_64083777 | 10.36 |
Gm20670 |
predicted gene 20670 |
26008 |
0.14 |
chr3_3011487_3011800 | 10.29 |
Gm28002 |
predicted gene, 28002 |
7414 |
0.26 |
chr17_3010836_3011161 | 10.19 |
Gm49792 |
predicted gene, 49792 |
31026 |
0.11 |
chr3_3025255_3025681 | 9.99 |
Gm27460 |
predicted gene, 27460 |
2289 |
0.38 |
chr7_64075922_64076081 | 9.98 |
Gm20670 |
predicted gene 20670 |
18399 |
0.16 |
chr7_64079891_64080216 | 9.76 |
Gm20670 |
predicted gene 20670 |
22451 |
0.15 |
chr3_3021276_3022044 | 9.71 |
Gm27460 |
predicted gene, 27460 |
6097 |
0.26 |
chr7_64087113_64087366 | 9.71 |
Gm20670 |
predicted gene 20670 |
29637 |
0.14 |
chr7_64090193_64090344 | 9.66 |
Gm20670 |
predicted gene 20670 |
32666 |
0.13 |
chr3_3010670_3010904 | 9.49 |
Gm28002 |
predicted gene, 28002 |
6558 |
0.26 |
chr7_64078364_64078626 | 9.40 |
Gm20670 |
predicted gene 20670 |
20893 |
0.15 |
chr4_3065131_3065385 | 9.25 |
Gm27878 |
predicted gene, 27878 |
13439 |
0.21 |
chr7_64073426_64073678 | 8.98 |
Gm20670 |
predicted gene 20670 |
15950 |
0.16 |
chr3_3006491_3006754 | 8.82 |
Gm28002 |
predicted gene, 28002 |
2393 |
0.37 |
chr17_3027368_3027533 | 8.78 |
Gm49792 |
predicted gene, 49792 |
14574 |
0.11 |
chr7_64087457_64087748 | 8.77 |
Gm20670 |
predicted gene 20670 |
30000 |
0.14 |
chr3_3027946_3028350 | 8.68 |
Gm27460 |
predicted gene, 27460 |
391 |
0.9 |
chr7_64076914_64077069 | 8.46 |
Gm20670 |
predicted gene 20670 |
19389 |
0.15 |
chr17_3020482_3020696 | 8.13 |
Gm49792 |
predicted gene, 49792 |
21435 |
0.11 |
chr4_3063425_3063705 | 7.91 |
Gm27878 |
predicted gene, 27878 |
11746 |
0.22 |
chr3_3022059_3022275 | 7.77 |
Gm27460 |
predicted gene, 27460 |
5590 |
0.27 |
chr4_3050051_3050467 | 7.73 |
Gm27878 |
predicted gene, 27878 |
1560 |
0.46 |
chr3_3022987_3023304 | 7.56 |
Gm27460 |
predicted gene, 27460 |
4612 |
0.28 |
chr3_3000208_3000480 | 7.32 |
Gm28002 |
predicted gene, 28002 |
3885 |
0.31 |
chr7_64084345_64084496 | 6.96 |
Gm20670 |
predicted gene 20670 |
26818 |
0.14 |
chr8_73619002_73619291 | 6.95 |
Gm23255 |
predicted gene, 23255 |
22359 |
0.27 |
chr4_3060229_3060445 | 6.89 |
Gm27878 |
predicted gene, 27878 |
8518 |
0.23 |
chr7_64088675_64088980 | 6.87 |
Gm20670 |
predicted gene 20670 |
31225 |
0.13 |
chr7_64085730_64086002 | 6.86 |
Gm20670 |
predicted gene 20670 |
28264 |
0.14 |
chr3_3000492_3000696 | 6.79 |
Gm28002 |
predicted gene, 28002 |
3635 |
0.31 |
chr4_3065839_3066007 | 6.71 |
Gm27878 |
predicted gene, 27878 |
14104 |
0.21 |
chr4_3062206_3062479 | 6.61 |
Gm27878 |
predicted gene, 27878 |
10523 |
0.22 |
chr3_3027780_3027931 | 6.54 |
Gm27460 |
predicted gene, 27460 |
98 |
0.98 |
chr4_3061022_3061296 | 6.49 |
Gm27878 |
predicted gene, 27878 |
9340 |
0.23 |
chr17_3025227_3025438 | 6.49 |
Gm49792 |
predicted gene, 49792 |
16692 |
0.11 |
chr3_3008173_3008517 | 6.46 |
Gm28002 |
predicted gene, 28002 |
4116 |
0.29 |
chr17_3018780_3018931 | 6.37 |
Gm49792 |
predicted gene, 49792 |
23169 |
0.11 |
chr4_3051905_3052056 | 6.37 |
Gm27878 |
predicted gene, 27878 |
161 |
0.97 |
chr4_3051368_3051519 | 6.26 |
Gm27878 |
predicted gene, 27878 |
376 |
0.9 |
chr17_3021386_3021537 | 6.25 |
Gm49792 |
predicted gene, 49792 |
20563 |
0.11 |
chr4_3079315_3079466 | 6.23 |
Vmn1r-ps2 |
vomeronasal 1 receptor, pseudogene 2 |
25202 |
0.17 |
chr16_3239765_3239916 | 6.17 |
Gm23215 |
predicted gene, 23215 |
9744 |
0.18 |
chr4_3059324_3059624 | 5.89 |
Gm27878 |
predicted gene, 27878 |
7655 |
0.23 |
chr3_3005542_3005915 | 5.89 |
Gm28002 |
predicted gene, 28002 |
1499 |
0.5 |
chr7_64077377_64077659 | 5.86 |
Gm20670 |
predicted gene 20670 |
19916 |
0.15 |
chr3_3004167_3004442 | 5.82 |
Gm28002 |
predicted gene, 28002 |
75 |
0.98 |
chr16_3238039_3238190 | 5.68 |
Gm23215 |
predicted gene, 23215 |
11470 |
0.18 |
chr3_3032535_3032686 | 5.39 |
Gm27460 |
predicted gene, 27460 |
4853 |
0.29 |
chr7_51626624_51628140 | 5.38 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
2098 |
0.31 |
chr3_3032938_3033274 | 5.36 |
Gm27460 |
predicted gene, 27460 |
5349 |
0.28 |
chr3_3016532_3016726 | 5.24 |
Gm27460 |
predicted gene, 27460 |
11128 |
0.24 |
chr4_3059728_3060005 | 5.18 |
Gm27878 |
predicted gene, 27878 |
8047 |
0.23 |
chr4_3052863_3053014 | 5.08 |
Gm27878 |
predicted gene, 27878 |
1119 |
0.58 |
chr12_9032043_9032272 | 5.00 |
Ttc32 |
tetratricopeptide repeat domain 32 |
2129 |
0.33 |
chr17_3020066_3020274 | 4.99 |
Gm49792 |
predicted gene, 49792 |
21854 |
0.11 |
chr4_3051547_3051758 | 4.88 |
Gm27878 |
predicted gene, 27878 |
167 |
0.96 |
chr7_64077743_64077894 | 4.88 |
Gm20670 |
predicted gene 20670 |
20216 |
0.15 |
chr17_3033506_3033657 | 4.87 |
Gm49792 |
predicted gene, 49792 |
8443 |
0.11 |
chr6_6857856_6858925 | 4.81 |
Gm44094 |
predicted gene, 44094 |
2139 |
0.2 |
chr17_3030579_3030730 | 4.70 |
Gm49792 |
predicted gene, 49792 |
11370 |
0.11 |
chr9_58197310_58202560 | 4.58 |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
637 |
0.54 |
chr19_45230983_45235468 | 4.51 |
Lbx1 |
ladybird homeobox 1 |
2587 |
0.27 |
chr3_3015370_3015521 | 4.40 |
Gm28002 |
predicted gene, 28002 |
11216 |
0.24 |
chr3_3028813_3029224 | 4.39 |
Gm27460 |
predicted gene, 27460 |
1261 |
0.56 |
chr7_79535310_79536820 | 4.35 |
Gm35040 |
predicted gene, 35040 |
22 |
0.95 |
chr7_64090415_64090660 | 4.33 |
Gm20670 |
predicted gene 20670 |
32935 |
0.13 |
chr3_3002672_3002823 | 4.33 |
Gm28002 |
predicted gene, 28002 |
1482 |
0.51 |
chr4_3053019_3053218 | 4.29 |
Gm27878 |
predicted gene, 27878 |
1299 |
0.52 |
chr17_3026210_3026390 | 4.27 |
Gm49792 |
predicted gene, 49792 |
15724 |
0.11 |
chr3_3009933_3010187 | 4.25 |
Gm28002 |
predicted gene, 28002 |
5831 |
0.27 |
chr4_3052110_3052261 | 4.10 |
Gm27878 |
predicted gene, 27878 |
366 |
0.9 |
chr7_64080796_64080964 | 4.08 |
Gm20670 |
predicted gene 20670 |
23278 |
0.15 |
chr17_3025810_3026167 | 4.07 |
Gm49792 |
predicted gene, 49792 |
16036 |
0.11 |
chr3_3026024_3026175 | 4.04 |
Gm27460 |
predicted gene, 27460 |
1658 |
0.46 |
chr3_3014493_3014644 | 3.99 |
Gm28002 |
predicted gene, 28002 |
10339 |
0.24 |
chr4_3066312_3066463 | 3.97 |
Gm27878 |
predicted gene, 27878 |
14568 |
0.21 |
chr7_144238658_144240098 | 3.90 |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
653 |
0.8 |
chr7_64076193_64076419 | 3.86 |
Gm20670 |
predicted gene 20670 |
18704 |
0.16 |
chr4_3064022_3064173 | 3.72 |
Gm27878 |
predicted gene, 27878 |
12278 |
0.21 |
chr7_5029343_5032174 | 3.68 |
Zfp865 |
zinc finger protein 865 |
1434 |
0.15 |
chr2_74688213_74688364 | 3.59 |
Hoxd10 |
homeobox D10 |
3636 |
0.07 |
chr7_64079415_64079566 | 3.53 |
Gm20670 |
predicted gene 20670 |
21888 |
0.15 |
chr9_26735341_26735832 | 3.51 |
B3gat1 |
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
1735 |
0.34 |
chr4_153479101_153480189 | 3.50 |
Ajap1 |
adherens junction associated protein 1 |
2534 |
0.43 |
chr4_3079519_3079670 | 3.49 |
Vmn1r-ps2 |
vomeronasal 1 receptor, pseudogene 2 |
24998 |
0.17 |
chr15_102973384_102974181 | 3.36 |
Mir196a-2 |
microRNA 196a-2 |
432 |
0.63 |
chr13_55827549_55829422 | 3.33 |
Gm47071 |
predicted gene, 47071 |
2235 |
0.21 |
chrX_152643367_152644550 | 3.23 |
Shroom2 |
shroom family member 2 |
34 |
0.98 |
chr7_64083837_64084142 | 3.19 |
Gm20670 |
predicted gene 20670 |
26387 |
0.14 |
chr1_42711455_42712692 | 3.18 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
1381 |
0.34 |
chr4_72195085_72196381 | 3.16 |
Tle1 |
transducin-like enhancer of split 1 |
3359 |
0.26 |
chrX_159459109_159459882 | 3.15 |
Map7d2 |
MAP7 domain containing 2 |
358 |
0.87 |
chr6_28829740_28830660 | 3.10 |
Lrrc4 |
leucine rich repeat containing 4 |
145 |
0.96 |
chr17_3022885_3023043 | 3.03 |
Gm49792 |
predicted gene, 49792 |
19060 |
0.11 |
chr7_131966504_131967699 | 3.02 |
Gpr26 |
G protein-coupled receptor 26 |
641 |
0.75 |
chr4_3064869_3065020 | 3.01 |
Gm27878 |
predicted gene, 27878 |
13125 |
0.21 |
chr13_94876260_94878233 | 3.00 |
Otp |
orthopedia homeobox |
1644 |
0.4 |
chr8_34890130_34891317 | 3.00 |
Tnks |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase |
572 |
0.8 |
chr2_70561988_70564432 | 2.98 |
Gad1os |
glutamate decarboxylase 1, opposite strand |
147 |
0.61 |
chr15_44746196_44747245 | 2.95 |
Sybu |
syntabulin (syntaxin-interacting) |
1068 |
0.56 |
chr4_3069818_3069969 | 2.95 |
Gm27878 |
predicted gene, 27878 |
18074 |
0.19 |
chr7_137306984_137307575 | 2.92 |
Ebf3 |
early B cell factor 3 |
6637 |
0.2 |
chr7_87586513_87587584 | 2.92 |
Grm5 |
glutamate receptor, metabotropic 5 |
2650 |
0.4 |
chr7_64086021_64086201 | 2.91 |
Gm20670 |
predicted gene 20670 |
28509 |
0.14 |
chr17_3010655_3010806 | 2.90 |
Gm49792 |
predicted gene, 49792 |
31294 |
0.11 |
chr19_6499251_6500132 | 2.87 |
Nrxn2 |
neurexin II |
1856 |
0.23 |
chr7_49911362_49912424 | 2.87 |
Slc6a5 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 5 |
193 |
0.96 |
chr15_85677376_85679232 | 2.86 |
Lncppara |
long noncoding RNA near Ppara |
24688 |
0.12 |
chr19_17574236_17574387 | 2.85 |
Gm17819 |
predicted gene, 17819 |
118452 |
0.06 |
chr15_78116860_78117881 | 2.84 |
A730060N03Rik |
RIKEN cDNA A730060N03 gene |
2336 |
0.22 |
chr2_74745819_74748448 | 2.81 |
Hoxd3 |
homeobox D3 |
1411 |
0.17 |
chr18_59063849_59064205 | 2.80 |
Minar2 |
membrane integral NOTCH2 associated receptor 2 |
1516 |
0.53 |
chr9_8900980_8902109 | 2.80 |
Pgr |
progesterone receptor |
1076 |
0.65 |
chr19_44765444_44765968 | 2.77 |
Pax2 |
paired box 2 |
5791 |
0.15 |
chr9_22050521_22051976 | 2.76 |
Elavl3 |
ELAV like RNA binding protein 3 |
762 |
0.41 |
chr3_3033343_3033494 | 2.75 |
Gm27460 |
predicted gene, 27460 |
5661 |
0.28 |
chr5_131532921_131534054 | 2.67 |
Auts2 |
autism susceptibility candidate 2 |
910 |
0.58 |
chr17_23682713_23684127 | 2.67 |
Cldn9 |
claudin 9 |
606 |
0.42 |
chr4_3066546_3066697 | 2.64 |
Gm27878 |
predicted gene, 27878 |
14802 |
0.21 |
chr12_24654236_24654405 | 2.60 |
Klf11 |
Kruppel-like factor 11 |
2166 |
0.24 |
chrX_7609972_7611295 | 2.55 |
Cacna1f |
calcium channel, voltage-dependent, alpha 1F subunit |
3489 |
0.1 |
chr18_37477814_37478721 | 2.54 |
Pcdhb16 |
protocadherin beta 16 |
453 |
0.57 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 26.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.0 | 3.0 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
1.0 | 1.0 | GO:0048880 | sensory system development(GO:0048880) |
1.0 | 3.0 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.9 | 7.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.9 | 2.7 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.8 | 2.5 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.8 | 1.7 | GO:0021564 | vagus nerve development(GO:0021564) |
0.8 | 6.6 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.8 | 2.3 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.8 | 1.5 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.8 | 2.3 | GO:0061205 | paramesonephric duct development(GO:0061205) |
0.7 | 2.8 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.7 | 2.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.7 | 0.7 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.6 | 0.6 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.6 | 1.8 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.6 | 1.8 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.6 | 0.6 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.6 | 2.2 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.5 | 2.7 | GO:0046958 | nonassociative learning(GO:0046958) |
0.5 | 1.6 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.5 | 7.1 | GO:0071625 | vocalization behavior(GO:0071625) |
0.5 | 2.7 | GO:0036233 | glycine import(GO:0036233) |
0.5 | 1.1 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.5 | 1.0 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.5 | 1.0 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.5 | 1.5 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.5 | 1.4 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.5 | 1.4 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.5 | 1.4 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.4 | 0.4 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.4 | 1.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.4 | 0.9 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.4 | 1.7 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.4 | 1.3 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.4 | 1.2 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.4 | 1.2 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.4 | 1.6 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.4 | 1.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.4 | 1.2 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.4 | 1.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.4 | 3.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.4 | 1.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.4 | 3.0 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.4 | 0.7 | GO:0072069 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.4 | 1.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.4 | 0.7 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.4 | 1.8 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.4 | 1.4 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.4 | 1.1 | GO:0048793 | pronephros development(GO:0048793) |
0.4 | 1.1 | GO:0035799 | ureter maturation(GO:0035799) |
0.3 | 3.4 | GO:0045176 | apical protein localization(GO:0045176) |
0.3 | 2.7 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.3 | 1.7 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.3 | 0.7 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.3 | 2.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.3 | 0.6 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.3 | 0.6 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.3 | 1.3 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.3 | 1.0 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 0.9 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.3 | 0.3 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
0.3 | 0.6 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.3 | 0.9 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.3 | 1.8 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.3 | 1.8 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.3 | 0.9 | GO:0033058 | directional locomotion(GO:0033058) |
0.3 | 0.6 | GO:0072289 | metanephric nephron tubule formation(GO:0072289) |
0.3 | 1.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.3 | 0.9 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.3 | 1.7 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.3 | 1.1 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.3 | 0.6 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.3 | 7.4 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.3 | 0.8 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.3 | 1.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.3 | 1.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.3 | 0.8 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.3 | 1.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.3 | 0.3 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.3 | 0.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.3 | 3.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.3 | 1.3 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.3 | 0.8 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 0.8 | GO:0009629 | response to gravity(GO:0009629) |
0.3 | 0.8 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 1.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 0.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 0.7 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.2 | 2.2 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.2 | 0.7 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.2 | 1.4 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.2 | 0.5 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 0.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.7 | GO:0060592 | mammary gland formation(GO:0060592) |
0.2 | 1.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.5 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.2 | 0.7 | GO:0014029 | neural crest formation(GO:0014029) |
0.2 | 0.9 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.2 | 4.7 | GO:0048665 | neuron fate specification(GO:0048665) |
0.2 | 0.6 | GO:0060166 | olfactory pit development(GO:0060166) |
0.2 | 0.6 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.2 | 0.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.6 | GO:0007494 | midgut development(GO:0007494) |
0.2 | 0.6 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 0.4 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.2 | 0.4 | GO:0060594 | mammary gland specification(GO:0060594) |
0.2 | 0.6 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.2 | 0.6 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.2 | 0.6 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.2 | 0.4 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.2 | 0.4 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.2 | 2.5 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.2 | 0.6 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.2 | 0.7 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 0.6 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 1.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 0.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 0.2 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.2 | 0.5 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.2 | 0.5 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 0.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 1.3 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.2 | 2.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 0.2 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
0.2 | 0.4 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 0.2 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.2 | 0.3 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.2 | 0.3 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.2 | 1.7 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.2 | 0.9 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.2 | 0.3 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 0.5 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.2 | 0.2 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.2 | 0.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.8 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 0.3 | GO:0021578 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
0.2 | 0.5 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.2 | 0.8 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.2 | 0.5 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.2 | 0.7 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.2 | 0.5 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.2 | 0.8 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.2 | 0.2 | GO:1903935 | response to sodium arsenite(GO:1903935) |
0.2 | 0.5 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.2 | 0.5 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.2 | 0.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.5 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.2 | 0.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 0.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 3.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 0.3 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 0.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 0.8 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 0.8 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.2 | 0.2 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.1 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.1 | 0.7 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.1 | 0.3 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.1 | 2.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.3 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.3 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.9 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.1 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.3 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.3 | GO:0048143 | astrocyte activation(GO:0048143) |
0.1 | 0.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.4 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.1 | 0.4 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.7 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.1 | 0.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 0.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 0.1 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.1 | 0.5 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.3 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.1 | 0.1 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.1 | 0.1 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.1 | 0.5 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 0.9 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.1 | 2.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.7 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 1.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.8 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.5 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.1 | 0.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 0.6 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.4 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 1.5 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 0.2 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.1 | 1.7 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.4 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.2 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.1 | 0.6 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.5 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.8 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.2 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 0.3 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.1 | 0.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.1 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.1 | 0.3 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.7 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.8 | GO:1901142 | insulin metabolic process(GO:1901142) |
0.1 | 0.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.1 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.1 | 0.3 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.3 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.1 | 0.9 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.6 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.1 | 0.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 0.8 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.8 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.1 | 0.3 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.2 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.3 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.9 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.3 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.1 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.1 | 0.3 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
0.1 | 3.5 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.1 | 0.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.7 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.4 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 0.4 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.1 | 0.2 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.1 | 0.6 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 0.2 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.1 | 0.2 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.1 | 0.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 1.0 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.3 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.2 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.1 | 0.3 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.3 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 0.4 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.3 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.2 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.9 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.5 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.2 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.1 | 0.3 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.3 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.1 | 0.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.7 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.7 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.1 | 0.1 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.1 | 0.2 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.1 | 0.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.1 | 0.1 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.1 | 0.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.1 | 0.6 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.3 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 0.5 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.1 | 0.8 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.1 | 0.5 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.4 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.1 | GO:1902563 | regulation of neutrophil activation(GO:1902563) |
0.1 | 0.3 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.1 | 0.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.3 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.1 | 2.6 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 0.3 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.2 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.1 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.1 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.1 | 0.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.7 | GO:0060004 | reflex(GO:0060004) |
0.1 | 0.4 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.3 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 0.1 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.1 | 0.3 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.1 | 0.1 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.1 | 0.3 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 0.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.1 | 0.3 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.7 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.6 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.2 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.1 | 0.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.3 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.1 | 0.2 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 0.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.2 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.8 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.1 | 0.5 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.2 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.2 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.1 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.1 | 0.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.1 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.1 | 0.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.4 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 0.5 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 1.2 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.6 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.1 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.3 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.7 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.2 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 0.6 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.2 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 0.2 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.1 | 0.1 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.1 | 3.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.2 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.2 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.1 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.1 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.3 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.1 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.2 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.3 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 0.2 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.1 | 0.2 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.4 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.1 | 0.2 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.1 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) |
0.1 | 0.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.1 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.2 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.1 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.1 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.1 | 0.2 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
0.1 | 0.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.1 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 0.1 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 0.8 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) |
0.1 | 0.1 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 0.5 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.7 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.1 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.7 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.2 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 0.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.1 | GO:0098815 | modulation of excitatory postsynaptic potential(GO:0098815) |
0.1 | 0.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.2 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) |
0.1 | 0.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.1 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.1 | 0.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.1 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.1 | 0.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.1 | 0.1 | GO:0045655 | regulation of monocyte differentiation(GO:0045655) |
0.1 | 0.3 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.2 | GO:0060214 | endocardium formation(GO:0060214) |
0.1 | 0.1 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.1 | 0.2 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.1 | 0.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 0.2 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.1 | 0.3 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.1 | 0.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.6 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.6 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 1.0 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 0.2 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.1 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.3 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.2 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.2 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.1 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) |
0.1 | 0.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.2 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.1 | 2.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.0 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.0 | 0.2 | GO:0060384 | innervation(GO:0060384) |
0.0 | 2.9 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.0 | 0.6 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.0 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.2 | GO:0051963 | regulation of synapse assembly(GO:0051963) |
0.0 | 0.1 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.5 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.3 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.0 | 0.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.0 | 0.3 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.0 | 1.4 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.0 | 0.4 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.1 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.0 | 0.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.0 | 0.1 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.0 | 0.1 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.0 | 0.1 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.0 | 0.1 | GO:0060751 | branch elongation involved in mammary gland duct branching(GO:0060751) |
0.0 | 0.0 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.0 | 0.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.0 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.0 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.0 | 1.9 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.0 | 0.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.0 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.0 | 0.0 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.2 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.0 | 0.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.2 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.0 | 0.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.1 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.0 | 0.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.0 | 0.4 | GO:0060074 | synapse maturation(GO:0060074) |
0.0 | 0.2 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.0 | 0.2 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.0 | 0.3 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.1 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.0 | 0.1 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.0 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.0 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.5 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.0 | 0.2 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.0 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.0 | 0.1 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.1 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
0.0 | 0.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 0.0 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.0 | 0.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.0 | 0.2 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.0 | 0.3 | GO:0030850 | prostate gland development(GO:0030850) |
0.0 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.1 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.0 | 0.0 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.0 | 0.3 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.0 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.0 | 0.0 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.0 | 0.4 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.0 | 0.0 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.2 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.1 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 0.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.0 | 0.0 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.0 | 0.3 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.0 | 0.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.0 | 0.1 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.0 | 0.0 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.0 | 0.1 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.7 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.0 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.0 | 0.1 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.1 | GO:1903798 | regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
0.0 | 0.1 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.0 | 0.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.0 | 0.1 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.0 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.0 | 0.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.0 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.0 | 0.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.0 | 0.1 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.0 | 0.0 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.0 | 0.2 | GO:0008207 | C21-steroid hormone metabolic process(GO:0008207) |
0.0 | 0.1 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.1 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.0 | 0.2 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.0 | 0.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.0 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.0 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.0 | 0.0 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.0 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.0 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.0 | 0.2 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.2 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.0 | 0.0 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.0 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.0 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.0 | GO:0061317 | canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) |
0.0 | 0.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.0 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.0 | 0.0 | GO:1903551 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.0 | 0.0 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.3 | GO:0031103 | axon regeneration(GO:0031103) |
0.0 | 0.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.0 | 0.0 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.0 | 0.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.0 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 0.2 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.5 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.1 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.0 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.0 | 0.6 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.0 | 0.0 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.0 | GO:0072071 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.0 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.2 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.0 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.1 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.0 | 0.1 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.0 | 0.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.0 | 0.0 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 0.2 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.1 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.0 | 0.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.1 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 0.0 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.0 | 0.0 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.0 | 0.0 | GO:0032252 | secretory granule localization(GO:0032252) |
0.0 | 0.0 | GO:0099612 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
0.0 | 0.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.0 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.0 | 0.0 | GO:0071869 | response to catecholamine(GO:0071869) |
0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.0 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.1 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.0 | 0.1 | GO:0097421 | liver regeneration(GO:0097421) |
0.0 | 0.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.2 | GO:1904851 | positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.0 | 0.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.0 | 0.1 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.0 | 0.0 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.0 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.0 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
0.0 | 0.0 | GO:0001839 | neural plate morphogenesis(GO:0001839) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.0 | GO:2000109 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.0 | 0.1 | GO:0031280 | negative regulation of cyclase activity(GO:0031280) |
0.0 | 0.0 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.0 | 0.0 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.1 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.0 | 0.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.0 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.0 | 0.0 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.0 | 0.0 | GO:1903897 | regulation of PERK-mediated unfolded protein response(GO:1903897) negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.0 | 0.0 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.0 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.0 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.0 | 0.1 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.2 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.0 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.0 | 1.0 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.0 | 0.0 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.0 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.0 | 0.0 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.0 | 0.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.0 | GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
0.0 | 0.0 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.0 | 0.0 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.0 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.0 | 0.0 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.0 | 0.0 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.0 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.0 | 0.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.0 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.0 | 0.0 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.1 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.0 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.0 | 0.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.0 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.0 | 0.1 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.0 | 0.1 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 | 0.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.0 | 0.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.0 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.0 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.0 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.0 | 0.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.1 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.0 | 0.1 | GO:0001709 | cell fate determination(GO:0001709) |
0.0 | 0.0 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.0 | 0.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.0 | 0.0 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.0 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.0 | GO:0014719 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) skeletal muscle satellite cell activation(GO:0014719) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.0 | 0.0 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.0 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.0 | 0.0 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.0 | 0.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.0 | 0.0 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.0 | 0.0 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.7 | 23.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.6 | 5.5 | GO:0005883 | neurofilament(GO:0005883) |
0.6 | 1.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 0.4 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.4 | 1.9 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.4 | 0.7 | GO:0044393 | microspike(GO:0044393) |
0.3 | 1.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 1.6 | GO:0097433 | dense body(GO:0097433) |
0.2 | 2.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 0.6 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 1.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 0.5 | GO:0000811 | GINS complex(GO:0000811) |
0.2 | 0.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 1.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 2.6 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 0.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 1.9 | GO:0097449 | astrocyte projection(GO:0097449) |
0.2 | 0.8 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 1.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 0.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 1.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 2.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 0.5 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 0.8 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 2.7 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 1.2 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.9 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 0.4 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 3.8 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.4 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 10.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 1.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 4.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.1 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.1 | 0.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 1.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.4 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.1 | 0.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.3 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 1.4 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 7.2 | GO:0034705 | potassium channel complex(GO:0034705) |
0.1 | 3.3 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 1.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 1.0 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 1.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 1.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.1 | 0.5 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.3 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 14.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.4 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 1.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 1.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 2.3 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 0.6 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 1.4 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.3 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 0.4 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 1.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 0.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.3 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.2 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.0 | GO:1904949 | ATPase complex(GO:1904949) |
0.0 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.0 | 0.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 1.7 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.5 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.0 | 0.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.3 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 1.8 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 0.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.3 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 1.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.4 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.1 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 1.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.2 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.0 | 0.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 1.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.1 | GO:0005712 | chiasma(GO:0005712) |
0.0 | 0.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.2 | GO:0043203 | axon hillock(GO:0043203) |
0.0 | 0.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.3 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.4 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 2.0 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.1 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.1 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.4 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 6.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 0.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.0 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.0 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.0 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.0 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.0 | 0.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 2.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 0.0 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.6 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.1 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.1 | GO:0031983 | vesicle lumen(GO:0031983) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 18.8 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.7 | 2.8 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.7 | 2.7 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.6 | 1.7 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.6 | 2.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.5 | 1.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.5 | 1.9 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.5 | 1.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.4 | 1.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.4 | 2.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 3.3 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.4 | 1.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.4 | 2.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 1.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.3 | 1.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 2.6 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.3 | 3.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.3 | 1.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 0.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 0.9 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.3 | 1.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.3 | 26.7 | GO:0005262 | calcium channel activity(GO:0005262) |
0.3 | 2.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 0.7 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 1.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 0.7 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 0.7 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 0.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.2 | 1.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.2 | 1.8 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.2 | 0.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 0.6 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 1.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 2.9 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 1.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 0.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.2 | 0.7 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 2.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 1.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 0.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.2 | 2.1 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.2 | 0.5 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 1.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 0.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 1.0 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.2 | 4.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 0.5 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.2 | 0.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 1.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 3.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 2.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 1.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 1.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 1.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 2.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.1 | 0.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.7 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 1.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.7 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.1 | 1.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 3.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.5 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 1.3 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 1.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 2.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 3.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 1.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 2.0 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 3.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 1.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 25.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 1.0 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 1.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 2.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.3 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 1.2 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 3.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.6 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.3 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 1.3 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 1.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 0.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.3 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 0.5 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.4 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 3.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.6 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.6 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 1.2 | GO:0022842 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.1 | 0.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.3 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 0.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.1 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 1.5 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.2 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.2 | GO:0034934 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 0.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.3 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 2.0 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.2 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 1.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.6 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 2.3 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.9 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.2 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.6 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.1 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.8 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.2 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.4 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.0 | 0.2 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.0 | 0.2 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.6 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 1.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 1.1 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.0 | 0.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 1.4 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 1.1 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.4 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 2.0 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.0 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.7 | GO:0035380 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.3 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.3 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.0 | 0.2 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 0.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.0 | 0.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.0 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.0 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.2 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.0 | 0.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.2 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.0 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.0 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.0 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.1 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.0 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.0 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.1 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.8 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0099528 | dopamine neurotransmitter receptor activity(GO:0004952) G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.0 | 0.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.6 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.0 | 0.6 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.1 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.1 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.0 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.0 | 0.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.0 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.1 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.0 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.0 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.0 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.0 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.0 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.0 | 0.2 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0046977 | TAP binding(GO:0046977) |
0.0 | 0.0 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 2.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 2.2 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 1.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 3.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 2.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 1.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 3.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 7.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 1.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 8.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 1.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 2.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.3 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.0 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 3.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 3.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.2 | 2.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 2.7 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.2 | 3.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 2.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 3.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 1.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 2.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 5.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.1 | 0.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 3.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 3.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 0.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 4.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 4.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.1 | 0.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 1.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.0 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 0.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 2.9 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.1 | 0.1 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.1 | 0.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 1.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.8 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 3.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.5 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.1 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.0 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.0 | 6.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 0.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.1 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.1 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.0 | 0.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.2 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |